Matthew Cooper, PhD, is a translational medical researcher and entrepreneur with expertise in diagnostics, drug discovery and the development of anti-microbial and anti-inflammatory therapies. He has founded four biotechnology companies with multiple products licensed or on the market. He also holds a fractional Professorial Research Fellow appointment at the University of Queensland, Australia, and at Trinity College Dublin, Ireland. He is a fellow of the Royal Society of Medicine and a member of the Royal Society of Chemistry.